PCPC, FDA Negotiate Oversight Bill With Possible State-Law Preemption
This article was originally published in The Rose Sheet
Executive Summary
While acknowledging that there is “a long, long way to go,” PCPC’s John Hurson says industry and FDA have reached a tentative framework for legislation that would update federal cosmetics regulations and possibly preempt state laws, which have become the bane of national cosmetics manufacturers.